Quantcast

Latest Goodwin Biotechnology Stories

2014-03-24 16:25:08

PLANTATION, Fla., March 24, 2014 /PRNewswire/ -- Goodwin Biotechnology, Inc. announced an agreement with Aspyrian Therapeutics, Inc. for the technology transfer, process development, scale-up, and cGMP manufacturing of a novel Antibody Drug Conjugate (ADC) for use in Phase I clinical trials. Aspyrian Therapeutics has secured an exclusive license from the National Cancer Institute for a new ADC technology platform, Near-infrared Photoimmunotherapy (PIT), which permits highly efficient and...

2014-03-05 12:27:04

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w2749d/antibody_drug) has announced the addition of the "Antibody Drug Conjugates: Contract Manufacturing Market, 2014 - 2024" [http://www.researchandmarkets.com/research/w2749d/antibody_drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The concept of Antibody drug conjugates (ADCs) is simple - a cytotoxic /...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related